Skip to main content

Publications

Found 169 results
Author Title [ Year(Asc)]
2019
Myers J, Myatt L, Roberts J, Redman C. COLLECT, a collaborative database for pregnancy and placental research studies worldwide. BJOG. 2019;126(1):8-10.  (127.54 KB)
Dube YPrudence, Ruktanonchai CWarren, Sacoor C, Tatem AJ, Munguambe K, Boene H, et al.. How accurate are modelled birth and pregnancy estimates? Comparison of four models using high resolution maternal health census data in southern MozambiqueBackgroundMethodsResultsConclusion. BMJ Global Health [Internet]. 2019;4(Suppl 5):e000894. http://gh.bmj.com/lookup/doi/10.1136/bmjgh-2018-000894https://syndication.highwire.org/content/doi/10.1136/bmjgh-2018-000894 (1.77 MB)
Magee LA, Sharma S, Nathan H, Adetoro OO, Bellad MB, Goudar S, et al.. The incidence of pregnancy hypertension in India, Pakistan, Mozambique, and Nigeria: A prospective population-level analysis. PLoS Med. 2019;16(4):e1002783.  (864.32 KB)
Makanga P, Sacoor C, Schuurman N, Lee T, Vilanculo F, Munguambe K, et al.. Place-specific factors associated with adverse maternal and perinatal outcomes in Southern Mozambique: a retrospective cohort study. BMJ Open. 2019;9(2):e024042.  (2.94 MB)
Macuácua S, Catalão R, Sharma S, Valá A, Vidler M, Macete E, et al.. Policy review on the management of pre-eclampsia and eclampsia by community health workers in Mozambique. Human Resources for Health [Internet]. 2019;17(1). https://human-resources-health.biomedcentral.com/articles/10.1186/s12960-019-0353-9http://link.springer.com/content/pdf/10.1186/s12960-019-0353-9.pdf (687.16 KB)
PRE- EMPT, Consortium. PRE-EMPT Selected scientific abstracts, 2011-2019. 2019;:1-81.  (21.32 MB)
Hofmeyr J, Betrán A, Singata-Madliki M, Cormick G, Munjanja S, Fawcus S, et al.. Prepregnancy and early pregnancy calcium supplementation among women at high risk of pre-eclampsia: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet. 2019;393(10169):330-339.  (10.3 MB)
Hofmeyr J, Novikova N, Singata-Madliki M, Fawcus S, Munjanja S, Belizan J. Protocol 11PRT/4028: Long term calcium supplementation in women at high risk of pre-eclampsia: a randomised, placebo-controlled trial. The Lancet [Internet]. 2019;. https://www.thelancet.com/protocol-reviews/11PRT-4028
Payne BA, von Dadelszen P, Bhutta ZA, Magee LA, Olalekan A, Sotunsa J, et al.. Protocol 13PRT/9313:The Community Level Interventions for Pre-eclampsia (CLIP) Trials: four prospective cluster randomised controlled trials comparing a package of interventions directed towards improving maternal and perinatal outcomes related to pre-ecl [Internet]. 2019 . https://clinicaltrials.gov/ct2/show/study/NCT01911494?term=01911494&rank=1
Sheikh S, Qureshi RNajam, Raza F, Memon J, Ahmed I, Vidler M, et al.. Self-reported maternal morbidity: Results from the community level interventions for pre-eclampsia (CLIP) baseline survey in Sindh, Pakistan. Pregnancy Hypertension. 2019;17:113 - 120.  (1.03 MB)
Ukah V, Payne BA, Karjalainen H, Kortelainen E, Seed P, Conti-Ramsden FInez, et al.. Temporal and external validation of the fullPIERS model for the prediction of adverse maternal outcomes in women with pre-eclampsia. Pregnancy Hypertens. 2019;15:42-50.  (887.01 KB)
2018
Cormick G, Betrán A, Harbron J, Purnat T, Parker C, Hall D, et al.. Are women with history of pre-eclampsia starting a new pregnancy in good nutritional status in South Africa and Zimbabwe?. BMC Pregnancy Childbirth. 2018;18(1):236.  (712.34 KB)
Ukah V, Payne BA, Hutcheon J, Ansermino JM, Ganzevoort J, Thangaratinam S, et al.. Assessment of the fullPIERS Risk Prediction Model in Women With Early-Onset Preeclampsia. Hypertension. 2018;71(4):659-665.  (237.99 KB)
Katageri G, Charantimath U, Joshi A, Vidler M, Ramadurg U, Sharma S, et al.. Availability and use of magnesium sulphate at health care facilities in two selected districts of North Karnataka, India. Reproductive Health [Internet]. 2018;15(S1). https://reproductive-health-journal.biomedcentral.com/articles/10.1186/s12978-018-0531-6http://link.springer.com/content/pdf/10.1186/s12978-018-0531-6.pdf (460.75 KB)
Magee LA, Synnes A, von Dadelszen P, Hutfield A, Chanoine J-P, Côté A-M, et al.. CHIPS-Child: Testing the developmental programming hypothesis in the offspring of the CHIPS trial. Pregnancy Hypertens. 2018;14:15-22.  (1011.52 KB)
Khowaja A, Mitton C, Qureshi R, Bryan S, Magee LA, von Dadelszen P, et al.. A comparison of maternal and newborn health services costs in Sindh Pakistan. PLoS One. 2018;13(12):e0208299.  (645.08 KB)
Nathan H, Boene H, Munguambe K, Sevene E, Akeju D, Olalekan A, et al.. The CRADLE vital signs alert: qualitative evaluation of a novel device designed for use in pregnancy by healthcare workers in low-resource settings. Reprod Health. 2018;15(1):5.  (394.63 KB)
Payne BA, Ryan H, Bone J, Magee LA, Aarvold A, Ansermino JM, et al.. Development and internal validation of the multivariable CIPHER (Collaborative Integrated Pregnancy High-dependency Estimate of Risk) clinical risk prediction model. Crit Care. 2018;22(1):278.  (961.71 KB)
Rocha B, Mbofana F, Loquiha O, Mudenyanga C, Ukah V, Magee LA, et al.. Early diagnosis of preeclampsia using placental growth factor: An operational pilot study in Maputo, Mozambique. Pregnancy Hypertens. 2018;11:26-31.  (374.54 KB)
Khowaja A. Economic evaluation of the Community-Level Interventions for Pre-eclampsia (CLIP) in Sindh, Pakistan. In 2018.  (2.53 MB)
Schmella M, Roberts J, Conley Y, Ren D, Storvold G, Ingles S, et al.. Endoglin pathway genetic variation in preeclampsia: A validation study in Norwegian and Latina cohorts. Pregnancy Hypertens. 2018;12:144-149.  (258.96 KB)
Charanthimath U, Vidler M, Katageri G, Ramadurg U, Karadiguddi C, Kavi A, et al.. The feasibility of task-sharing the identification, emergency treatment, and referral for women with pre-eclampsia by community health workers in India. Reprod Health. 2018;15(Suppl 1):101.
Sacoor C, Payne BA, Augusto O, Vilanculo F, Nhacolo A, Vidler M, et al.. Health and socio-demographic profile of women of reproductive age in rural communities of southern Mozambique. PLoS One. 2018;13(2):e0184249.  (3.25 MB)
Pels A, Mol B, Singer J, Lee T, von Dadelszen P, Ganzevoort J, et al.. Influence of Gestational Age at Initiation of Antihypertensive Therapy: Secondary Analysis of CHIPS Trial Data (Control of Hypertension in Pregnancy Study). Hypertension. 2018;71(6):1170-1177.  (303.94 KB)
De Silva D, Synnes A, von Dadelszen P, Lee T, Bone J, Magee LA. MAGnesium sulphate for fetal neuroprotection to prevent Cerebral Palsy (MAG-CP)-implementation of a national guideline in Canada. Implement Sci. 2018;13(1):8.  (1.89 MB)
Ukah V, De Silva D, Payne BA, Magee LA, Hutcheon J, Brown H, et al.. Prediction of adverse maternal outcomes from pre-eclampsia and other hypertensive disorders of pregnancy: A systematic review. Pregnancy Hypertens. 2018;11:115-123.  (501.41 KB)
Velicky P, Windsperger K, Petroczi K, Pils S, Reiter B, Weiss T, et al.. Pregnancy-associated diamine oxidase originates from extravillous trophoblasts and is decreased in early-onset preeclampsia. Sci Rep. 2018;8(1):6342.  (3.16 MB)
2017
Tsigas E. Advocacy is essential to supporting women with pre-eclampsia. Obstet Med. 2017;10(1):33-35.  (85.27 KB)
Myatt L, Roberts J, Redman C. Availability of COLLECT, a database for pregnancy and placental research studies worldwide. Placenta. 2017;57:223-224.  (141.67 KB)
Hofmeyr J, Manyame S. Calcium supplementation commencing before or early in pregnancy, or food fortification with calcium, for preventing hypertensive disorders of pregnancy. Cochrane Database Syst Rev. 2017;9:CD011192.  (116.05 KB)
Marianne V. Community perceptions of the hypertensive disorders of pregnancy. In 2017.  (2.63 MB)
Burton G, Jauniaux E. The cytotrophoblastic shell and complications of pregnancy. Placenta. 2017;60:134-139.  (1.81 MB)
Allotey J, Marlin N, Mol B, von Dadelszen P, Ganzevoort J, Akkermans J, et al.. Development and validation of prediction models for risk of adverse outcomes in women with early-onset pre-eclampsia: protocol of the prospective cohort PREP study. Diagnostic and Prognostic Research. 2017;1(1).  (428.07 KB)
Ukah V, Mbofana F, Rocha B, Loquiha O, Mudenyanga C, Usta M, et al.. Diagnostic Performance of Placental Growth Factor in Women With Suspected Preeclampsia Attending Antenatal Facilities in Maputo, Mozambique. Hypertension. 2017;69(3):469-474.  (378.99 KB)
Conrad K, Rabaglino M, Uiterweer E. Emerging role for dysregulated decidualization in the genesis of preeclampsia. Placenta. 2017;60:119-129.  (1.43 MB)
Ukah V, Payne BA, Lee T, Magee LA, von Dadelszen P. External Validation of the fullPIERS Model for Predicting Adverse Maternal Outcomes in Pregnancy Hypertension in Low- and Middle-Income Countries. Hypertension. 2017;69(4):705-711.  (149.83 KB)
Schalekamp-Timmermans S, Arends L, Alsaker E, Chappell L, Hansson S, Harsem N, et al.. Fetal sex-specific differences in gestational age at delivery in pre-eclampsia: a meta-analysis. Int J Epidemiol. 2017;46(2):632-642.  (530.75 KB)
Ukah V. THE fullPIERS RISK PREDICTION MODEL FOR WOMEN WITH PRE-ECLAMPSIA: EXTERNAL VALIDATION, RECALIBRATION AND ADDED VALUE OF A NOVEL BIOMARKER (PLACENTAL GROWTH FACTOR). In 2017.  (2.49 MB)
Vaiman D. Genes, epigenetics and miRNA regulation in the placenta. Placenta. 2017;52:127-133.  (495.08 KB)
Molla Y, Rawlins B, Makanga P, Cunningham M, Ávila JEugenio He, Ruktanonchai C, et al.. Geographic information system for improving maternal and newborn health: recommendations for policy and programs. BMC Pregnancy Childbirth. 2017;17(1):26.  (3.02 MB)
Roberts J, Hansson S, Vaiman D, Redman C. Global Pregnancy Collaboration symposium on placental health: Summary and recommendations. Placenta. 2017;52:116-121.  (440.44 KB)
Roberts J, Redman C. Global Pregnancy Collaboration symposium: Prepregnancy and very early pregnancy antecedents of adverse pregnancy outcomes: Overview and recommendations. Placenta. 2017;60:103-109.  (216.45 KB)
Sebire N. Implications of placental pathology for disease mechanisms; methods, issues and future approaches. Placenta. 2017;52:122-126.  (966.86 KB)
Gibson P, Narous M, Firoz T, Chou D, Barreix M, Say L, et al.. Incidence of myocardial infarction in pregnancy: a systematic review and meta-analysis of population-based studies. Eur Heart J Qual Care Clin Outcomes. 2017;3(3):198-207.  (575.39 KB)
Mateus J, Newman R, Sibai B, Li Q, Barton J, C Combs A, et al.. Massive Urinary Protein Excretion Associated with Greater Neonatal Risk in Preeclampsia. AJP Rep. 2017;7(1):e49-e58.  (184.83 KB)
Bellad M, Vidler M, Honnungar N, A M, Ramadurg U, Charanthimath U, et al.. Maternal and Newborn Health in Karnataka State, India: The Community Level Interventions for Pre-Eclampsia (CLIP) Trial's Baseline Study Results. PLoS One. 2017;12(1):e0166623.  (2.12 MB)
Lissauer D, Kilby M, Moss P. Maternal effector T cells within decidua: The adaptive immune response to pregnancy?. Placenta. 2017;60:140-144.  (435.5 KB)
Gammill H, Harrington W. Microchimerism: Defining and redefining the prepregnancy context - A review. Placenta. 2017;60:130-133.  (200.23 KB)
Burton G, Yung H, Murray A. Mitochondrial - Endoplasmic reticulum interactions in the trophoblast: Stress and senescence. Placenta. 2017;52:146-155.  (3.07 MB)
Aarvold A, Ryan H, Magee LA, von Dadelszen P, Fjell C, Walley K. Multiple Organ Dysfunction Score Is Superior to the Obstetric-Specific Sepsis in Obstetrics Score in Predicting Mortality in Septic Obstetric Patients. Crit Care Med. 2017;45(1):e49-e57.  (910.16 KB)

Pages